A photo of Mi-Ok Kim.

Mi-Ok Kim, PhD

Biostatistician, Biostatistics and Epidemiology

Associate Professor, UC Department of Pediatrics

Phone 513-636-1895

Fax 513- 636-7509

Email miok.kim@cchmc.org


Causal inference; comparative effectiveness research; longitudinal and survival data analysis; adaptive clinical trial designs

MS: Statistics, University of Illinois, Urbana-Champaign, IL.

PhD: Statistics, University of Illinois, Urbana-Champaign, IL, 2003.

View PubMed Publications

Kim MO, Liu C, Hu F, Lee JJ. Outcome-Adaptive Randomization for a Delayed Outcome with a Short-Term Predictor: Imputation Based Designs. Statistics in Medicine. 2014 May 29.

Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan S, Denson LA. Utility of Neutrophil Fcγ Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohn's Disease. Inflamm Bowel Dis. 2014 Jun;20(6):1037-48.

Walters TD, Kim MO*, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS; PRO-KIIDS Research Group. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb;146(2):383-91. (*co-primary authors)

Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA. Increased Prevalence of Luminal Narrowing and Stricturing Identified by Enterography in Pediatric Crohn's Disease Patients With Elevated Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies. Inflammatory Bowel Diseases. 2013 Sep;19(10):2146-54.

Gathungu G, Kim MO, Ferguson JP, Sharma Y, Zhang W, Ng SM, Bonkowski E, Ning K, Simms LA, Croft AR, Stempak JM, Walker N, Huang N, Xiao Y, Silverberg MS, Trapnell B, Cho JH, Radford-Smith GL, Denson LA. Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies: A Marker of Aggressive Crohn's Disease. Inflammatory Bowel Diseases. 2013 Jul;19(8):1671-1680.

Choi D, Hoffman KA, Kim MO, McCarty D. A High Resolution Evaluation of Process Improvement:Use of Quantile Regression for Wait Time. Health Services Research. 2013 Feb;48(1):333-47.

Kim MO, Yang Y. Semiparametric Approach to a Random Effects Quantile Regression Model. Journal of the American Statistical Association. 2011, Dec 1: 106(496): 1405-1417.

Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ. A Randomized Controlled Trial of Growth Hormone in Active Pediatric Crohn's Disease. Journal of Pediatric Gastroenterology and Nutrition. 2010; Aug;51(2):130-9.

Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology. 2009 Apr;136(4):1261-71, e1-3.

Kim M-O. Quantile Regression with Varying Coefficients. Annals of Statistics. 2007;35(1): 92-108.

Cincinnati Center for Excellence in Molecular Hematology. Biostatistician. National Institutes of Health. Sep 2010–June 2015. P30DK090971-01 (Zheng).                             

Lineage Determination and Tissue HomeOstasis in the aged Hematopoietic System. Biostatistician. National Institutes of Health. Aug 2011–July 2016. R01 AG040118 (Zheng).                                       

Risk Stratification & Identification of immunogenic and microbial markers of rapid disease progression in children with Crohn’s disease. Co-Investigator. Crohn's & Colitis Foundation of America. July 2008-June 2017. R01 (Denson/Kugathasan).

Causes and Consequences of Neutrophil Dysfunction in Pediatric Crohns Disease. Director (Biostatistics Core). National Institutes of Health. Sep 2013–July 2018. R01DK098231 (Denson).

Neurofibroma Preclinical Therapeutics. Co-Investigator. The Children’s Tumor Foundation. July 2013–July 2016. CTF (Ratner).

Macrophage Based Gene Therapy for Hereditary Pulmonary Alveolar Proteinosis. Co-Investigator. National Institutes of Health. April 2014–March 2018. R01 (Trapnell).                                              

Rigor of Multi-Registry CER Studies: Towards Patient-Centered Treatment Planning. Principal Investigator. National Institutes of Health / Agency for Healthcare Research and Quality. July 2014–June 2016. K18 (Kim).